Susquehanna International Group, LLP Clovis Oncology, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.05 - $2.85 $688,742 - $1.87 Million	-655,945 Reduced 56.48%	505,343 $601,000
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.96 $105,639 - $496,338	167,682 Added 16.88%	1,161,288 $2.09 Million
Q1 2022 May 16, 2022	SELL	$1.43 - $3.14 $518,053 - $1.14 Million	-362,275 Reduced 26.72%	993,606 $2.01 Million
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $283,224 - $499,314	104,898 Added 8.39%	1,355,881 $3.68 Million
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $1.31 Million - $1.88 Million	323,597 Added 34.89%	1,250,983 $5.58 Million
Q2 2021 Aug 11, 2021	BUY	$5.02 - $7.05 $971,435 - $1.36 Million	193,513 Added 26.37%	927,386 $5.38 Million
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $215,382 - $463,004	44,778 Added 6.5%	733,873 $5.15 Million
Q4 2020 Feb 16, 2021	SELL	$4.13 - $6.41 $1.02 Million - $1.58 Million	-246,180 Reduced 26.32%	689,095 $3.31 Million
Q3 2020 Nov 16, 2020	SELL	$4.82 - $7.72 $1.22 Million - $1.95 Million	-253,087 Reduced 21.3%	935,275 $5.45 Million
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $1.07 Million - $1.82 Million	188,216 Added 18.82%	1,188,362 $8.02 Million
Q1 2020 May 15, 2020	BUY	$3.77 - $11.0 $3.64 Million - $10.6 Million	966,111 Added 2838.58%	1,000,146 $6.36 Million
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $254,433 - $1.39 Million	-84,811 Reduced 71.36%	34,035 $355,000
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $1.68 Million - $6.57 Million	-427,766 Reduced 78.26%	118,846 $467,000
Q2 2019 Aug 16, 2019	BUY	$12.81 - $25.67 $708,136 - $1.42 Million	55,280 Added 11.25%	546,612 $8.13 Million
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $5.5 Million - $11 Million	429,286 Added 691.88%	491,332 $7.31 Million
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $10.7 Million - $18.3 Million	-603,466 Reduced 90.68%	62,046 $1.54 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $3.93 Million - $11 Million	337,948 Added 103.17%	665,512 $12 Million
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $5.81 Million - $9.79 Million	197,807 Added 152.44%	327,564 $9.62 Million
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $6.47 Million - $9.6 Million	-153,908 Reduced 54.26%	129,757 $5.9 Million
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $4.14 Million - $5.59 Million	-82,508 Reduced 22.53%	283,665 $15 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $14.5 Million - $21.2 Million	250,808 Added 217.4%	366,173 $24.9 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $7.75 Million - $9.78 Million	115,365	115,365 $9.51 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account